Related Experiment Video
Updated: May 22, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB
Tz-Chuen Ju1, Yow-Sien Lin, Yijuang Chern
1Division of Neuroscience, Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei 11529, Taiwan.
Insights
Huntington's disease (HD) involves a CAG repeat expansion, leading to cellular dysfunction and neurodegeneration. This review explores how disruptions in energy homeostasis, particularly involving key molecular determinants, contribute to HD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
- It stems from a CAG trinucleotide expansion in the Huntingtin (Htt) gene, resulting in a polyglutamine-expanded Htt protein.
- This expansion leads to cytotoxicity, affecting cellular machinery and causing progressive symptoms like movement disorders, cognitive decline, and dementia.
Purpose of the Study:
- To review the role of cellular energy homeostasis in HD pathogenesis.
- To highlight three key molecular determinants of energy regulation: peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), AMP-activated protein kinase (AMPK), and creatine kinase B (CKB).
- To discuss the potential involvement of these factors in HD.
Main Methods:
- Literature review focusing on recent studies.
- Analysis of molecular mechanisms underlying energy dysregulation in HD.
- Examination of the roles of PGC-1α, AMPK, and CKB in cellular energy homeostasis and their connection to HD.
Main Results:
- HD is characterized by significant brain atrophy, particularly in the striatum and cortex.
- Beyond neuronal defects, mitochondrial dysfunction and altered energy homeostasis are increasingly recognized as critical in HD progression.
- Dysregulation of PGC-1α, AMPK, and CKB may represent important pathogenic pathways in HD.
Conclusions:
- Energy dysregulation is a significant factor in Huntington's disease pathogenesis.
- Investigating the roles of PGC-1α, AMPK, and CKB offers potential therapeutic targets for HD.
- Further research into these molecular determinants is crucial for understanding and treating HD.
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. When the number of CAG repeats exceeds 36, the translated polyglutamine-expanded Htt protein interferes with the normal functions of many types of cellular machinery and causes cytotoxicity. Clinical symptoms include progressive involuntary movement disorders, psychiatric signs, cognitive decline, dementia, and a shortened lifespan. The most severe brain atrophy is observed in the striatum and cortex. Besides the well-characterized neuronal defects, recent studies showed that the functions of mitochondria and several key players in energy homeostasis are abnormally regulated during HD progression. Energy dysregulation thus is now recognized as an important pathogenic pathway of HD. This review focuses on the importance of three key molecular determinants (peroxisome proliferator-activated receptor-γ coactivator-1α, AMP-activated protein kinase, and creatine kinase B) of cellular energy homeostasis and their possible involvement in HD pathogenesis.
More Related Videos
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
Related Concept Videos
Huntington Disease l: Introduction
cAMP-dependent Protein Kinase Pathways
Parkinson Disease ll: Pathophysiology
GPCRs Regulate Adenylyl Cylase Activity
Two...
Pharmacogenomics: Identification of New Drug Targets
Cell Specific Gene Expression